Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
4.210
+0.260 (6.58%)
At close: Oct 24, 2025, 4:00 PM EDT
4.290
+0.080 (1.90%)
After-hours: Oct 24, 2025, 7:48 PM EDT

Larimar Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
360247200179191329
Upgrade
Market Cap Growth
-19.78%23.61%11.79%-6.49%-41.88%-
Upgrade
Enterprise Value
2264911060119233
Upgrade
Last Close Price
4.213.874.554.1310.7921.41
Upgrade
PB Ratio
2.251.442.441.612.973.67
Upgrade
P/TBV Ratio
3.011.442.441.612.973.67
Upgrade
Debt / Equity Ratio
0.040.030.070.050.090.07
Upgrade
Quick Ratio
5.247.589.1611.067.9510.31
Upgrade
Current Ratio
5.468.029.4911.288.1610.89
Upgrade
Return on Equity (ROE)
-60.25%-63.59%-38.36%-40.33%-65.72%-95.47%
Upgrade
Return on Assets (ROA)
-35.04%-38.36%-23.48%-22.26%-34.40%-48.69%
Upgrade
Return on Capital (ROIC)
-39.73%-43.00%-25.64%-24.45%-37.86%-55.96%
Upgrade
Earnings Yield
-27.69%-32.64%-18.50%-19.78%-26.50%-12.92%
Upgrade
FCF Yield
-25.70%-28.86%-16.83%-15.48%-22.21%-12.85%
Upgrade
Buyback Yield / Dilution
-24.61%-39.53%-70.42%-50.09%-44.44%-95.09%
Upgrade
Updated Aug 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q